I was asking Tonoos why it's taking so long for the FDA to respond. I recall GTHP submitted info early last year and the FDA was late in responding. What are you babbling about?
BB will want to take it private, when its still cheap....then after a few years of getting the implant for use on other indications, they will go for an IPO and make 5x their investment.
Wouldn't their opinion be a conflict of interest since they are the underwriters.
IPO? This is a secondary offering. The price is pretty much set and the buyer(s) are already lined up. They'll release a PR when the deal closes, most likely around the time of the conference.
Did you read the second paragraph? This sounds pretty detailed to me.
"The Company intends to use the net proceeds received from the sale of the common stock for general corporate purposes, including clinical trial expenses, research and development expenses, general and administrative expenses, manufacturing expenses and potential acquisitions of companies and technologies that complement its business."
You should ask yourself why the price didn't fall to $2.90 or less. It's currently 50 cents higher than the offering which is awesome!
Sentiment: Strong Buy
Is that sarcasm John? Even with the offering at $2.90, the pps is holding at $3.40. Is that strength or what? I haven't estimated what their burn rate is, but after closing they're adding $55 Million to something like $40+ Million? So they are positioning themselves to go it alone on P3 HPV, or being in a stronger negotiating position to partner up?